A business model developed at Harvard Business School and applied in the real world proves that Big Pharma can simultaneously earn additional profits and expand access to lifesaving drugs, if firms ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Kathleen Elkins Every time Kathleen publishes a story, you’ll get an alert straight to your ...
Forbes contributors publish independent expert analyses and insights. Melissa Houston covers financial issues that affect women in business. Creating a revenue-generating business model is essential ...